(Q44671618)

5 December 2017

title

Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells (English)

1 reference

5 December 2017

1 reference

1 reference

L T Martin

1

1 reference

5 December 2017

A Faraj

2

1 reference

5 December 2017

R F Schinazi

3

1 reference

5 December 2017

G Gosselin

4

1 reference

5 December 2017

C Mathe

5

1 reference

5 December 2017

J L Imbach

6

1 reference

5 December 2017

J P Sommadossi

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

5 December 2017

published in

Biochemical Pharmacology

1 reference

5 December 2017

volume

53

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

75-87

1 reference

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

A preliminary trial of lamivudine for chronic hepatitis B infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

(-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Freshly isolated or cryopreserved human hepatocytes in primary culture: Influence of drug metabolism on hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Deoxycytidine and 2',3'-dideoxycytidine metabolism in human monocyte-derived macrophages. A study of both anabolic and catabolic pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900653-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(96)00653-3

1 reference

5 December 2017

1 reference